← Back to Search

Brief Intervention for Alcohol Use in Injured Patients

N/A
Waitlist Available
Led By Garth H. Utter, MD, MSc
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mentally and physically able to provide consent and participate in the intervention
Admission to the trauma ward or ICU
Must not have
Non-English or Non-Spanish Speaking
<18 yrs old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether providing brief interventions to people who drink alcohol excessively will help to change their drinking behavior and avoid negative consequences such as injuries, arrests, and harmful drinking.

Who is the study for?
This trial is for adults over 18 who've been admitted to the trauma ward or ICU, can speak English or Spanish, and are able to consent. It's not for those under 18, non-English/Spanish speakers, people with severe psychiatric illnesses, or those incarcerated.
What is being tested?
The study tests if a short motivational talk can change drinking habits in injured patients. The goal is to see if this reduces re-hospitalizations due to alcohol-related injuries, DUI arrests, and harmful drinking patterns.
What are the potential side effects?
Since the intervention involves only a brief counseling session without any medical drugs or procedures involved, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am mentally and physically capable of agreeing to and participating in the study.
Select...
I have been admitted to the trauma ward or ICU.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English or Spanish.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hospital re-admissions
Secondary study objectives
12 month AUDIT Results
Moving violations/DUI
Self referral for counselling/treatment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Intervention group receives pamphlet on alcohol and self referral information in addition to brief motivational interview
Group II: 1Active Control1 Intervention
Control group to receive informational pamphlet on alcohol use and list of self referral agencies
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Motivational Interview
2015
N/A
~350

Find a Location

Who is running the clinical trial?

California Office of Traffic SafetyOTHER_GOV
2 Previous Clinical Trials
1,064 Total Patients Enrolled
University of California, DavisLead Sponsor
946 Previous Clinical Trials
4,755,300 Total Patients Enrolled
Garth H. Utter, MD, MScPrincipal InvestigatorUniversity of California, Davis

Media Library

Brief Motivational Interview Clinical Trial Eligibility Overview. Trial Name: NCT00278785 — N/A
Wound Research Study Groups: 2, 1
Wound Clinical Trial 2023: Brief Motivational Interview Highlights & Side Effects. Trial Name: NCT00278785 — N/A
Brief Motivational Interview 2023 Treatment Timeline for Medical Study. Trial Name: NCT00278785 — N/A
~83 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top